dhhs/ohrp proposed new rule making
DESCRIPTION
DHHS/OHRP Proposed New Rule Making. July 26, 2011 60 day public comment period ends: Monday, October 26, 2011 !! Paul J. Reitemeier, Ph.D., Chair Human Research Review Committee Note: Slides used courtesy of PRIM&R webinar with permission. DHHS/OHRP Proposed New Rule Making. - PowerPoint PPT PresentationTRANSCRIPT
1
DHHS/OHRPProposed New Rule Making
July 26, 2011 60 day public comment period ends:
Monday, October 26, 2011 !!
Paul J. Reitemeier, Ph.D., Chair
Human Research Review Committee
Note: Slides used courtesy of PRIM&R webinar with permission
2
DHHS/OHRPProposed New Rule Making
3
DHHS/OHRPProposed New Rule Making
4
DHHS/OHRPProposed New Rule Making
5
DHHS/OHRPProposed New Rule Making
DHHS/OHRPProposed New Rule Making
6
DHHS/OHRPProposed New Rule Making
7
DHHS/OHRPProposed New Rule Making
8
DHHS/OHRPProposed New Rule Making
9
DHHS/OHRPProposed New Rule Making
10
DHHS/OHRPProposed New Rule Making
11
DHHS/OHRPProposed New Rule Making
12
DHHS/OHRPProposed New Rule Making
13
DHHS/OHRPProposed New Rule Making
14
DHHS/OHRPProposed New Rule Making
15
DHHS/OHRPProposed New Rule Making
16
DHHS/OHRPProposed New Rule Making
17
DHHS/OHRPProposed New Rule Making
18
DHHS/OHRPProposed New Rule Making
19
DHHS/OHRPProposed New Rule Making
20
DHHS/OHRPProposed New Rule Making
21
DHHS/OHRPProposed New Rule Making
22
DHHS/OHRPProposed New Rule Making
23
DHHS/OHRPProposed New Rule Making
24
DHHS/OHRPProposed New Rule Making
25
DHHS/OHRPProposed New Rule Making
26
DHHS/OHRPProposed New Rule Making
27
DHHS/OHRPProposed New Rule Making
28
DHHS/OHRPProposed New Rule Making
29
DHHS/OHRPProposed New Rule Making
30
DHHS/OHRPProposed New Rule Making
31
DHHS/OHRPProposed New Rule Making
32
DHHS/OHRPProposed New Rule Making
33
DHHS/OHRPProposed New Rule Making
34
DHHS/OHRPProposed New Rule Making
35
DHHS/OHRPProposed New Rule Making
36
DHHS/OHRPProposed New Rule Making
37
DHHS/OHRPProposed New Rule Making
38
DHHS/OHRPProposed New Rule Making
39
DHHS/OHRPProposed New Rule Making
40
DHHS/OHRPProposed New Rule Making
41
DHHS/OHRPProposed New Rule Making
42
DHHS/OHRPProposed New Rule Making
43
DHHS/OHRPProposed New Rule Making
44
DHHS/OHRPProposed New Rule Making
45
DHHS/OHRPProposed New Rule Making
46
DHHS/OHRPProposed New Rule Making
47
DHHS/OHRPProposed New Rule Making
48
DHHS/OHRPProposed New Rule Making
49
DHHS/OHRPProposed New Rule Making
50
DHHS/OHRPProposed New Rule Making
51
DHHS/OHRPProposed New Rule Making
52
DHHS/OHRPProposed New Rule Making
53
DHHS/OHRPProposed New Rule Making
54
DHHS/OHRPProposed New Rule Making
55
DHHS/OHRPProposed New Rule Making
56
DHHS/OHRPProposed New Rule Making
57
DHHS/OHRPProposed New Rule Making
58
DHHS/OHRPProposed New Rule Making
59
DHHS/OHRPProposed New Rule Making
60
DHHS/OHRPProposed New Rule Making
61
DHHS/OHRPProposed New Rule Making
62
DHHS/OHRPProposed New Rule Making
63
DHHS/OHRPProposed New Rule Making
64
DHHS/OHRPProposed New Rule Making
65
DHHS/OHRPProposed New Rule Making
66
SUMMARY RISK ASSESSMENT: framework refined (Section II);
Replace the “exempt” category with "excused" category. Excused research:
Expanded and clarified list of categories Would not require IRB review, only filing notices + audit system Would be subject to DHHS regulation and oversight Would require registration with & auditing by the institution Expand EXCUSED category 101(b)(2) (surveys, interviews) to
include all research on competent adults, incl. w/personal identifiers & sensitive data
Expand EXCUSED category 101(b)(4) (research on existing data sets) to include all data sets if: New initial consent standards are met @ time of collection
and study results are not ret’d to participants (not excused if ret’d)
67
SUMMARY EXPEDITED REVIEW:
Federal panel to expand and clarify categories No Continuing Review req’d for most studies
FULL BOARD REVIEW: No Continuing Review req’d for data analysis or routine
clinical follow-up
Up/AE: Timely PI reports still req’d for UP/AE and proposed
protocol changes. Federal collection/analysis of all UP/AE reports proposed
68
SUMMARY MULTI-SITE STUDIES: Require using a single IRB
review for all domestic sites (Section III);
CONSENT: Revised consent process and forms (Sec. IV); May require verbal consent for some excused
research studies, e.g., educational surveys, tests Require some language, incl. boilerplate sections
for common types of research Proscribe some language, esp. institutional Limit length of some sections in consent
document
69
SUMMARY BIOSPECIMENS: Require documented informed consent
to collect, bank or conduct research on human tissue specimens. Applies to all clinical collections.
EXPANDED COVERAGE: Extend federal regulatory protections to all research, regardless of funding source, if conducted at US institutions receiving any federal funding from a Common Rule agency for research with human subjects (Section VII); (in for a penny, in for a pound)
HARMONIZATION: Improve consistency of regulations and agency guidance for all Common Rule subscriber agencies (Section VIII).
70
SUMMARY DATA SECURITY: Require that HIPAA
Privacy rule standards (for defining Personally Identifiable Information, limited data set and de-identification) be applied to all research regardless of whether the research was conducted as part of a HIPAA Covered Entity for all studies that involve identifiable or potentially identifiable data (Section V); No IRB review for informational risk of any
study (per institution adopting HIPAA data standards universally)
71
SUMMARYDATA SECURITY: For research involving personal identifiers, human biospecimens, and limited data sets, the security standards could require the use of:
1. encryption for archiving and transmitting in electronic form,
2. strong physical safeguards for paper forms, audit trails, and access controls
3. Researchers required to adhere to breach notification standards modeled on HIPAA stds.
4. Researchers using limited data sets or de-identified information, strictly prohibited from attempting to re-identify the subjects of the information.
5. No IRB review for informational risk of any study (per institution adopting HIPAA data stds universally)
72
SUMMARY LIMITING IRB CREEP: Require reporting to DHHS
of any IRB protocol review upgrades: i.e., determinations that override default review requirements Conducting full-board reviews of research that may
have otherwise qualified for expedited review, Conducting expedited review of research that would
have qualified as exempt/excused.
Emphasis is to limit autonomy of IRB to “creep” or overreach its authority under the regulations. Allows unspecified independent institutional ethics review which may be IRB based.
73
DHHS/OHRPProposed New Rule Making
74
DHHS/OHRPProposed New Rule Making
75
DHHS/OHRPProposed New Rule Making
Center For Scholarly and Creative Excellence Research Protections Program
Human Research Review Committee [email protected]
RPP Office: 331-3197 Seth Galligan (GA) Jordan Fink (student worker) Christina Moord (Research Protections
Coordinator)